Yixuan Gong

Yixuan Gong

Department of Hematology/Oncology, Icahn School of Medicine at Mount Sinai

Affiliated withIcahn School of Medicine at Mount Sinai Icahn School of Medicine at Mount Sinai

Research Area

Medicine

Biography

Yixuan Gong has not added Biography.
If you are Yixuan Gong and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2015

Other Publications

Article	Year
3,3'-diindolylmethane is a novel topoisomerase IIalpha catalytic inhibitor that induces S-phase retardation and mitotic delay in human hepatoma HepG2 cells. Molecular pharmacology\| PubMed ID: 16385077	2006
3,3'-Diindolylmethane is a novel mitochondrial H(+)-ATP synthase inhibitor that can induce p21(Cip1/Waf1) expression by induction of oxidative stress in human breast cancer cells. Cancer research\| PubMed ID: 16651444	2006
Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitors. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 17085664	2006
Development of new mouse lung tumor models expressing EGFR T790M mutants associated with clinical resistance to kinase inhibitors. PloS one\| PubMed ID: 17726540	2007
Induction of BIM is essential for apoptosis triggered by EGFR kinase inhibitors in mutant EGFR-dependent lung adenocarcinomas. PLoS medicine\| PubMed ID: 17927446	2007
Novel MEK1 mutation identified by mutational analysis of epidermal growth factor receptor signaling pathway genes in lung adenocarcinoma. Cancer research\| PubMed ID: 18632602	2008
Dual targeting of EGFR can overcome a major drug resistance mutation in mouse models of EGFR mutant lung cancer. The Journal of clinical investigation\| PubMed ID: 19759520	2009
High expression levels of total IGF-1R and sensitivity of NSCLC cells in vitro to an anti-IGF-1R antibody (R1507). PloS one\| PubMed ID: 19806209	2009
EGFR mutant lung cancer. Current topics in microbiology and immunology\| PubMed ID: 21866438	2012
The emerging role of circulating tumor cell detection in genitourinary cancer. The Journal of urology\| PubMed ID: 22578722	2012
TIMP-1 promotes accumulation of cancer associated fibroblasts and cancer progression. PloS one\| PubMed ID: 24143225	2013
Reduced NF1 expression confers resistance to EGFR inhibition in lung cancer. Cancer discovery\| PubMed ID: 24535670	2014
Roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progression. Cancers\| PubMed ID: 24978435	2014
Elevated circulating tissue inhibitor of metalloproteinase 1 (TIMP-1) levels are associated with neuroendocrine differentiation in castration resistant prostate cancer. The Prostate\| PubMed ID: 25560638	2015
The antidiabetic compound 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione, isolated from Averrhoa carambola L., demonstrates significant antitumor potential against human breast cancer cell... Oncotarget\| PubMed ID: 26203774	2015
A robust blood gene expression-based prognostic model for castration-resistant prostate cancer. BMC medicine\| PubMed ID: 26297150	2015